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Abstract
What role do asymptomatically infected individuals play in the transmission dynam-
ics? There are many diseases, such as norovirus and influenza, where some infected hosts
show symptoms of the disease while others are asymptomatically infected, i.e. do not show
any symptoms. The current paper considers a class of epidemic models following an SEIR
(Susceptible → Exposed → Infectious → Recovered) structure that allows for both symp-
tomatic and asymptomatic cases. The following question is addressed: what fraction ρ of
those individuals getting infected are infected by symptomatic (asymptomatic) cases? This
is a more complicated question than the related question for the beginning of the epidemic:
what fraction of the expected number of secondary cases of a typical newly infected indi-
vidual, i.e. what fraction of the basic reproduction number R0, is caused by symptomatic
individuals? The latter fraction only depends on the type-specific reproduction numbers,
while the former fraction ρ also depends on timing and hence on the probabilistic distribu-
tions of latent and infectious periods of the two types (not only their means). Bounds on ρ
are derived for the situation where these distributions (and even their means) are unknown.
Special attention is given to the class of Markov models and the class of continuous-time
Reed-Frost models as two classes of distribution functions. We show how these two classes
of models can exhibit very different behaviour.
Keywords: two-type SEIR epidemic; final size; type of infector; continuous-time Reed-Frost
models; Markov models
1 Introduction
For many known human infectious diseases we have, to some extent, an idea about their clinical
features, e.g. the typical incubation period and common symptoms associated to them. Despite
this, there can be large heterogeneity between infected hosts in a population. Some infected
individuals may never show symptoms of disease (i.e. are asymptomatic) while others do (i.e. are
symptomatic). Suppose that we can categorize infected individuals as either asymptomatic or
symptomatic, and that some significant fraction of the infected host population is asymptomatic.
Then, even if asymptomatics make up a large part of the infected host population, can we say
how important their role is in the transmission dynamics?
In order to answer such a question, one needs to define the meaning of ‘importance’. A natural
approach is to consider the beginning of the epidemic, in particular the basic reproduction number
R0. This approach was taken by [1], where they considered the (weighted) contribution θ of
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infectious individuals without symptoms (either asymptomatically infected or prior to symptom
onset) to the basic reproduction number. The idea is that if θ is small, i.e. most of the secondary
cases in the beginning of an epidemic are caused by symptomatic individuals, then control
measures such as isolation of such (in principle detectable) individuals would greatly reduce
spreading whereas this approach may not be successful if θ is large.
In case of an emerging infectious disease such as the recent 2013-2015 Ebola outbreak, one
will mostly be interested in (controlling) the beginning of the outbreak. In such cases, we want to
understand epidemiological quantities such as R0 and θ. However, in case of infectious diseases
such as seasonal influenza in the general population, it is quite usual that major outbreaks occur.
In particular, the infectious disease is present in the population beyond its initial phase of the
outbreak. In the current paper we are interested in the fraction ρ of the final epidemic size that
were infected by symptomatic cases. Understanding the contribution of symptomatic cases to
the final size leads to better insights into possible transmission routes, but also how things would
change when e.g. removing a fraction of symptomatic individuals.
We consider a simple class of epidemic models that we call the symptom-response SEIR
epidemic models, defined in Section 2. This class of models has an SEIR (Susceptible→ Exposed
→ Infectious → Recovered) structure. The time that an individual spends in either the exposed
or infectious period can take on some general distributions. In particular, these distributions need
not necessarily be exponentially distributed or be the same for symptomatic and asymptomatic
cases. We can use the standard toolbox for analyzing mathematical models for infectious disease
dynamics to derive e.g. the basic reproduction number and the final size. In fact, these and other
characteristics have been studied before, e.g. in [2], which we will make use of.
Characterizing the fraction ρ turns out to be much more complicated than the related fraction
θ that only deals with the beginning of the outbreak on a generation basis. Whereas θ only
depends on the type-specific reproduction numbers (i.e. the expected number of secondary cases
generated by a newly infected individual that is either symptomatic or asymptomatic), the
fraction ρ also depends on the mean latent and infectious periods of the two types as well as
their probabilistic distributions. The general characterization of ρ, given in Section 3, does not
provide much insight even though it may be computed numerically when all distributions and
parameters are given. Because of this, and the fact that distributions of latent and infectious
periods are rarely fully known, it is of interest to give upper and lower bounds for ρ. In a ‘twin’
paper [3] we use probabilistic tools to derive bounds for ρ for the setting where these distributions
(including their means) are unknown (but note that [3] is more general than determining the
upper- and lower bound for the symptom-response SEIR model). In Section 3.2 of the current
paper, we present these bounds and explain the heuristics in deriving them. Moreover, we
are interested in two special classes of the model, namely the class of Markov models with
exponentially distributed latent and infectious periods and the class of continuous-time Reed-
Frost models with constant latent and infectious periods. We show that the choice of distribution
functions can have significant qualitative differences on the time-evolution of the epidemic by
comparing the class of Markov models with the Reed-Frost models having identical means.
Furthermore, in Section 4 we consider different scenarios in order to gain insights into ρ through
numerical investigation and to illustrate numerically the qualitative differences between Markov
models and Reed-Frost models.
2
2 Model definition
2.1 The stochastic symptom-response SEIR epidemic model
The stochastic symptom-response SEIR epidemic model is defined as follows (in our twin pa-
per [3] we study a more general form of the current model). We consider a closed population of
homogeneously mixing individuals, all being equally susceptible. We let n denote the number
of individuals in the population. The specific feature of the model is that infected individuals
can either become symptomatic or asymptomatic. In order not to confuse Symptomatic with
Susceptible, we use subscript d to denote symptomatic individuals, i.e. the individuals that show
signs of the d isease. Individuals are initially susceptible (S). If an individual gets infected it
becomes symptomatic with probability pd and asymptomatic with the remaining probability
pa = 1 − pd. These events are independent between individuals and also independent of whom
the individual was infected by (see [4] for a situation where the response does depend on the
infector).
We let S(t) denote the number of individuals in the population that are Susceptible at time
t. If the individual becomes symptomatic, it first has a random latency period Ld (and we let
E(t) with a subscript a or d denote the number of asymptomatic and symptomatic individuals
in the population at time t that are infected and Exposed but not yet infectious) followed by
a random infectious period ιd (where we let I(t) with subscripts a and d denote the number
of Infectious individuals that are asymptomatic and symptomatic). Symptomatic individuals
have infectious contacts at rate λd during the infectious period, each time with a uniformly
chosen individual in the population. Infectious contacts with susceptible individuals result in
the latter getting infected. Other infectious contacts have no effect on the epidemic (hence
the term infectious contacts). The situation for asymptomatic cases is analogous with latency
period La, infectious period ιa, and infectious contact rate λa. When the infectious period of an
individual terminates, the individual recovers and becomes immune (where R(t) with subscript
a and d denotes the number Recovered individuals that were asymptomatic or symptomatic) for
the rest of the epidemic. Note that S(t) + Ed(t) + Ea(t) + Id(t) + Ia(t) + Rd(t) + Ra(t) = n.
The epidemic starts with a small number of infectious individuals and all other individuals
susceptible. The end of the epidemic is at time T , where T is the first time that there are no
more latent or infectious individuals around. At time T there are only susceptible and recovered
individuals. Let Zd = Rd(T ) and Za = Ra(T ) be the final number (previously) symptomatic and
asymptomatic cases, respectively (so S(T ) = n− (Zd + Za)). The overall number of individuals
infected is denoted by Z = Zd + Za. We are mainly interested in large population sizes and
hence study the situation where n → ∞. Moreover, we let S¯(t) = S(t)/n and we define other
population quantities decorated with a bar over it in an analogous fashion. The limit of Zd/Z
as n→∞ conditioning on Z →∞ is simply the probability pd that a newly infected individual
becomes a symptomatic case, and Zd/n→ pdz, where z is the large population limit fraction of
the population getting infected in case of a major outbreak (and is characterised by the final size
equation (3) below).
Note that we have not specified anything about symptoms and when they appear. In fact,
we could equally well model a situation with mildly infected and severely infected (or two types
1 and 2 for that matter; see also [3]). Having symptomatic cases in mind, the contact rate
λd should reflect both the more likely situation that symptomatic cases have a higher viral
load as compared to asymptomatic cases (thus leading to higher transmission probability upon
contact), and the fact that symptomatic cases may reduce their number of social contacts and
thus meet fewer individuals. Since the infectious contact rate reflect both components, it need
not necessarily be that λd > λa.
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Note that if there are no latency periods (Ld ≡ La ≡ 0) the model reduces to an SIR model.
Furthermore, we give special attention to two distributions for latent and infectious period when
studying S(E)IR models. The first class of distributions is where both latency and infectious
periods follow exponential distributions, giving rise to Markov models. In the deterministic
setting this corresponds to the model being described by ordinary differential equations (ODE).
The second class of distributions is where these periods are non-random, i.e. fixed and the same for
all symptomatic (asymptomatic) individuals. We refer to this class of models as continuous-time
Reed-Frost epidemic models, since the events to infect different individuals are then independent.
In the deterministic setting such models can be described with integral equations.
2.1.1 Basic reproduction numbers and the final size
If we do not distinguish symptomatic and asymptomatic cases, the model defined in Section 2.1
falls under the general framework of epidemic models defined in [5], and treated specifically
in [2]. The fundamental quantity is the distribution of C, the (random) number of infectious
contacts that an infected individual has during its infectious period. To this end, let the random
variables Cd and Ca denote the number of infectious contacts for symptomatic and asymptomatic
individuals, respectively.
The final size distribution is completely determined by the distribution of C (which in turn is
specified by Cd, Ca and pd). For the symptom-response SEIR model, C follows a mixed Poisson
distribution: MixPo
(
λd1dιd + λa(1 − 1d)ιa
)
(all random variables being independent and not
necessarily exponentially distributed), where 1d is 1 with probability pd and 0 otherwise. Note
that the latency periods La and Ld have no effect on the number of infections – they only affect
the timing of the outbreak.
The basic reproduction number denotes the expected number of infectious contacts and equals
R0 = E(C) = pd E(Cd)+(1−pd)E(Ca) = pdλd E(ιd)+(1−pd)λa E(ιa) = pdR0,d+(1−pd)R0,a, (1)
where we call R0,d = λd E(ιd) and R0,a = λa E(ιa) the type-specific reproduction numbers for
newly infected symptomatic and asymptomatic individuals, respectively. We denote the fraction
of R0 that is caused by symptomatic individuals by θd, so
θd =
pdR0,d
R0
. (2)
(Note that [1] consider the quantity θ = 1− θd for a related but different model.)
Next, we make use of known results on the final size Z from [2]. First of all, if R0 > 1, then
the final fraction infected Z¯ = Z/n converges to a two-point distribution with probability mass
at 0 (small outbreaks) and at another point z, where z is the unique positive solution to the
equation
1− z = e−R0z (3)
(major outbreaks). So, if R0 ≤ 1 only minor outbreaks are possible. The probability for a major
outbreak depends more delicately on the distribution of C, and not only on its mean (e.g. [2]).
Second of all, in case of a minor outbreak, Z has a limiting distribution described by the finite
part of the distribution of the total progeny of a branching process with offspring distribution
C. Moreover, there is a central limit theorem for Z¯ in case of a major outbreak.
We use these results on the final size in the present paper. However, our focus is different:
we are interested in the number of cases that got infected by symptomatic and asymptomatic
individuals, respectively. Here, we let Yd and Ya denote the number of individuals that got
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infected by a symptomatic and asymptomatic case, respectively (so Z = Ya + Yd). We are
interested in the law of large number limit ρd that denotes the fraction of infected individuals
that get infected by symptomatic cases, given a major outbreak. We hence seek the limit ρd of
Yd/Z as n→∞ conditioning on Z →∞ (note the symmetry in asymptomatic and symptomatic
cases, ρa+ρd = 1, so we can just as well switch the roles of a and d). We turn to this in Section 3.
2.2 Deterministic symptom-response epidemic models
As with nearly all epidemic models, the current model may be approximated by a determin-
istic epidemic model when the population size is large enough and when the number of in-
dividuals in the different compartments are large enough. More specifically, when n is large,
(S¯(t), E¯a(t), E¯s(t), I¯a(t), I¯d(t), R¯a(t), R¯d(t)) may be approximated by a deterministic model on
the part of the time axis where all fractions are not too close to 0. The latter means that the
approximation does not work in the beginning nor at the end of an outbreak (when the number
of latent and infectious individuals are moderate to small), since these settings imply that the
corresponding fractions are close to 0. If the epidemic is initiated by a small positive fraction
of infected people (either latent or infectious and symptomatic or asymptomatic), the starting
phase is removed. In that case the approximation applies on any fixed time interval [0, t].
The statement that the stochastic model may be approximated by a deterministic counterpart
really should mean that there is a law of large number theorem that proves that, as n → ∞,
the stochastic process for the fractions converge in probability, uniformly on bounded intervals,
to the deterministic process. It is not the purpose of the present paper to prove such results for
the current model. Instead we assume this to hold and therefore work interchangeably with the
deterministic and stochastic setting. The law of large numbers should be proven using population
process theory (e.g. Ethier and Kurtz, 2006) in ways similar to what has been done for related
models, cf. [6], Section 3.4.
In the deterministic formulation of the model, we let the population size n→∞ and consider
expected fractions of the population in different disease states. The corresponding population
quantities are denoted by a small letter, i.e. s(t) is the expected fraction of the population that
is susceptible at t, and similarly for other population quantities.
We do the bookkeeping using the age τ since infection, taking into account asymptomatic
and symptomatic cases. Let
πa(τ) := P (La ≤ τ ≤ La + ιa) (4)
i.e. πa(τ) denotes the probability that an asymptomatic individual is infectious at age since
infection τ . Furthermore, let Fa(t) denote the force of infection from asymptomatic individuals
at time t (and similarly we have πd(τ) and Fd(g) for symptomatics). So, if ia(t) and id(t)
denote the fraction of individuals that are asymptomatic infectious and symptomatic infectious
respectively, then Fa(t) = λaia(t) and Fd(t) = λdid(t). Furthermore,
s˙ = −(Fa + Fd)s. (5)
From (5) it follows that the expected incidence at time t− τ is (Fa(t − τ) + Fd(t − τ))s(t − τ).
Of this quantity, a fraction pa = 1− pd is asymptomatic. An asymptomatic individual that was
infected time t− τ ago has expected infectivity λaπa(τ) at time t. Then, by integrating over all
possible ages since infection τ ≥ 0, we find an expression for Fa(t) (and similarly for Fd(t)):
Fa(t) =
∫
∞
0
λaπa(τ)(1 − pd)
(
Fa(t− τ) + Fd(t− τ)
)
s(t− τ)dτ
Fd(t) =
∫
∞
0
λdπd(τ)pd
(
Fa(t− τ) + Fd(t− τ)
)
s(t− τ)dτ.
(6)
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Together, (5) and (6) form a closed system. From this system, one can obtain e.g. the mean
fraction eA(t) of the population that is asymptomatically infected and still in the latent period.
To this end, we simply note that an asymptomatic individual that was infected time t−τ ago is in
its latent period with probability P (La > τ). Therefore, the fraction of exposed asymptomatic-
to-be individuals is
ea(t) =
∫
∞
0
P (La > τ)(1 − pd)
(
Fa(t− τ) + Fd(t− τ)
)
s(t− τ)dτ,
and similarly one can recover the formulas for the other population quantities.
2.2.1 Markov models
Often in the modelling community, ordinary differential equations (ODE) are used to describe
deterministic compartmental disease models. Implicitly this assumes that an individual spends
an exponentially distributed amount of time in each disease compartment, giving rise to the
special case of Markov models. Assume that Lk ∼ exp(αk), ιk ∼ exp(γk), k = a, d. Then, by
working out the probability πk, k = a, d, to be infectious at age-since infection τ :
πk(τ) =
αk
γk − αk
(
e−αkτ − e−γkτ
)
.
In ODE formulation, the dynamics of the model are described by
s′ = −(λaia + λdid)s
e′k = pk(λaia + λdid)s− αkek
i′k = αkek − γkik
r′k = γkik,
(7)
k = a, d, with pa = 1 − pd. Note that consistency requires 1 = s(t) + ea(t) + ia(t) + ra(t) +
ed(t) + id(t) + rd(t). As mentioned earlier, the forces of infection satisfy Fa(t) = λaia(t) and
Fd(t) = λdid(t). Finally, note that the type-specific reproduction numbers R0,a and R0,d reduce
to R0,a = λa/γa and R0,d = λd/γd (exactly as one would expect from the interpretation).
2.2.2 Continuous time Reed-Frost models
Another special class of models is when each individual spends a deterministic amount of time in
each disease compartment. We refer to this class of models as continuous-time Reed-Frost models.
This class of models plays an essential role in both this paper and the twin paper [3]. Assume
that Lk ≡ ℓk, and ιk ≡ xk, k = a, d, with ℓk, xk nonnegative constants (so all symptomatics have
equal lengths of latent and infectious periods, as do all asymptomatics). Then
πk(τ) = 1(ℓk,ℓk+xk)(τ),
k = a, d. This yields the following renewal equations for the forces of infection Fk:
Fk(t) =
∫ t−ℓk
t−(ℓk+xk)
pkλk(Fa(τ) + Fd(τ))s(τ)dτ, (8)
6
k = a, d and pa = 1 − pd. By differentiating with respect to t, we can reformulate (8) as delay
differential equations (DDE), and we end up with a system of three DDE for s, Fa, and Fd:
s(t)′ = −(Fa(t) + Fd(t))s(t)
Fk(t)
′ = pkλk
{(
Fa(t− ℓk) + Fd(t− ℓk)
)
s(t− ℓk)
−
[
Fa
(
t− (ℓk + xk)
)
+ Fd
(
t− (ℓk + xk)
)]
s
(
t− (ℓk + xk)
)}
,
(9)
k = a, d and pa = 1−pd. For given values of ℓa, ℓd, xa, and xd it is straightforward to numerically
simulate s, Fa, and Fd.
Finally, note that type-specific reproduction numbers R0,a and R0,d reduce to R0,a = λaxa
and R0,d = λdxd.
2.3 Initial conditions
So far, we have not specified initial conditions, i.e. how infection is introduced into the susceptible
population at the beginning of the epidemic. In general, in a stochastic formulation, one of two
options is chosen. There is at time t = 0, either a positive fraction of infectious individuals, or
a fixed number of infectious individuals, as the population size n → ∞. In other words, if we
let µn = n
−1mn, then, in the first case, µn → µ as n→ ∞, with µ > 0 constant. In the second
case, mn = m is fixed (and therefore µn → 0 as n → ∞). In general, the initial conditions can
matter for the possible courses that the epidemic can take, see e.g. [7]. Implicitly, for the basic
reproduction number and the final size of the epidemic, we assume the second setting of a fixed
number mn = m (but approximately the same results apply if µ > 0 but very small).
As we discuss in Section 2.2, the stochastic model of Section 2.1 can be approximated by a
deterministic epidemic model when the population size n is large enough. In the deterministic
formulation we implicitly assume an infinite population size and work with mean fractions of
the population. In particular, if we define the initial condition at t = 0, there is a strictly
positive fraction of infected individuals in the population at the beginning of the epidemic. This
corresponds to an infinite number of infecteds, no matter how small this fraction is. One way
to obtain the setting of an epidemic with only few infectious individuals at the beginning is by
starting with a small positive fraction of infected individuals at time t = 0 (chosen in the right
way), and then to let this fraction tend to zero while also letting time t→ −∞. This is how we
formulated (5)-(6) without worrying too much about initial conditions. In the ‘far past’ t = −∞,
the population is completely susceptible. If R0 > 1 and we let t → +∞, then an epidemic
outbreak will occur with final size characterized by (3) (in case of a major outbreak). It is not
the purpose of this paper to make these arguments fully rigorous. See also [8, Appendix A: The
early stages’].
Together with the ‘far past’ conditions, the deterministic model allow for the derivation of
R0 and the final size. By doing so, we find (1) for R0 and (3) for the final size. In particular,
the interpretation of R0 and the final size is the same as in the stochastic reasoning. In fact,
the law of large numbers results from [5] show that there is convergence of these epidemiological
quantities of the stochastic process to the deterministic process as population size n→∞.
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3 Who is the infector?
3.1 Timing matters
Now that we have set up the model framework in Section 2, we can ask: who is the infector?
We assume that a major outbreak occurs and the final number of infected individuals Z → ∞.
In particular, R0 > 1. In the remainder of the text we take the deterministic viewpoint, while
making use of probabilistic arguments. Assume that the final fraction of infected individuals Z¯
converges to z, where z is the nontrivial solution of (3). Recall from Section 2.1.1 that we let
ρa = 1− ρd and ρd denotes the fraction of z that had a symptomatic infector.
At time t, the rate at which new infections are caused by symptomatics is Fd(t)s(t), and the
rate at which new infections are caused by asymptomatics is Fa(t)s(t). The fraction of individuals
infected by symptomatic individuals is obtained by integrating over the entire epidemic. In
particular,
ρd =
∫
∞
−∞
Fd(t)s(t)dt∫
∞
−∞
(Fa(t) + Fd(t))s(t)dt
=
∫
∞
−∞
Fd(t)s(t)dt
z
. (10)
Note that indeed z =
∫
∞
−∞
(Fa(t) + Fd(t))s(t)dt (integrate both left- and right-hand side of (5)
over all time and observe that s(∞) = 1 − z, s(−∞) = 1). In principle, this characterizes ρd.
A different characterization for ρd involving the Malthusian parameter and (generally implicit)
limiting random variables of branching processes can be found in [3, Theorem 2.7]. However,
in general, both the expression (10) for ρd and the alternative expression of [3] are not very
informative and we have not managed to make either of them more explicit in this general
setting.
Due to the issues with obtaining general results for ρd mentioned above, we instead derive
general bounds for ρd in Section 3.2. First, we obtain explicit expressions of ρd for the very
special case that πa(τ) = πd(τ) for all τ , i.e. asymptomatic and symptomatic cases have the
same probability to be infectious at any given age-since-infection. From (6), we find that
Fa(t) =
(1 − pd)λa
pdλd
Fd(t).
Therefore,
z =
∫
∞
−∞
(Fa(t) + Fd(t))s(t)dt =
(
1 +
(1− pd)λa
pdλd
)∫
∞
−∞
Fd(t)s(t)dt,
leading to
ρd =
pdλd
pdλd + (1− pd)λa
=
pdR0,d
R0
, (11)
where the second equality follows from E(ιa) = E(ιd). Note that (11) is monotonically increasing
in both pd and λd. Furthermore, the fraction ρd only depends on the type-specific reproduction
numbers R0,a and R0,d and the probability pd. In fact, (11) is equal to the quantity θd (see (2))
that indicates the importance of symptomatics at the beginning of an epidemic.
Additionally, if also λd = λ = λa, the expression (11) reduces even further to
ρd = pd. (12)
8
3.2 General upper- and lower bounds on ρd
Two features of ρd seem obvious, but we have not been able to prove them since ρd depends
on the distributions of the latent and infectious periods in a rather complicated way (see (10)).
Instead we conjecture the two features regarding ρd and explain why we believe them to be
true. First, we believe that ρd is increasing in pd (and hence decreasing in pa = 1 − pd). This
means that, keeping all other parameters fixed, the fraction infected by symptomatic individuals
increases with the probability that an infected individual becomes a symptomatic case. Secondly,
we believe that ρd is increasing in λd (and decreasing in λa). Note that in the special case that
latent and infectious periods of symptomatics and asymptomatics are identical, i.e. πa(τ) = πd(τ)
for all τ , we find from (11) that these two statements regarding monotonicity of ρd hold true.
Note that as pd or λd changes, the overall fraction infected z also changes. We believe
that when one keeps R0 fixed (and therefore also z) as well as R0,d, the statements regarding
monotonicity of ρd in pd and λd remain true. If we change λd while keeping R0 and R0,d =
λd E(ιd) fixed, we also need to change the mean infectious period E(ιd). In the case that we
change pd, also R0,a changes.
Even though we believe the monotonicity of ρd in pd and λd to hold, there is little qualitative
insight that we can obtain from (10). Therefore, we derive explicit ranges within which ρd will
certainly lie, when keeping the reproduction numbers R0, R0,d, and R0,a fixed (and consequently
also pd = 1 − pa), in particular since in many situations the exact distributions of latent and
infectious periods are not known in detail.
Now we provide an intuitive argument for our beliefs on the monotonicity of ρd and the
extreme model that provides us an upper bound ρ+d (and for symmetry reasons also a lower
bound ρ−d ). Consider one newly infected symptomatic individual. Suppose we shorten the latent
period of this individual to zero and we make its infectious pressure very intense (by decreasing
the infectious period and at the same time increasing its infectious contact rate so that the
product remains constant), then this individual can cause infections earlier on in the epidemic
when there are more susceptible individuals. So more contacts will result in infections, i.e.
this symptomatic individual will cause more infections. By assuming that the new latent and
infectious periods are deterministic, we ensure that the symptomatic individual actually cause
more infections rather than only making it more probable (which would be the case with e.g. the
Markov assumption). Moreover, increasing the latent period of an asymptomatic individual will
imply that it can only start infecting others later on in the epidemic. Note that by assuming that
asymptomatics also have very intense infectious pressure, this also implies that the symptomatic
secondary cases they generate become infectious earlier on in the epidemic as well. It seems
reasonable that by applying the changes in latent and infectious periods to all individuals in the
population, i.e. if we consider an extreme case of the class of continuous-time Reed-Frost models
where La is long relative to Ld, ιa, and ιd, and very short ιa and ιd combined with very large
λa and λd, the extreme model will lead to an upper bound in ρd for all models with fixed R0,
R0,d, and R0,a. Of course, all of this is by no means a proof (for the proof as well as the precise
assumptions we need for the latent and infectious periods we refer to [3]), but we hope that this
convinces the reader why ρ+d is the upper bound (and/or encourages the reader to read [3]).
The proof in [3] uses an epidemic graph construction that couples susceptibility processes with
backward branching processes. The general idea in the proof presented in [3] is that there is a
shortest (directed) path from the individual that is infectious at the beginning of the epidemic to
the individual under consideration. Only the type of the neighbour with an edge pointing towards
the individual under consideration determines whether it got infected by an asymptomatic or
symptomatic case. We can determine this by considering the backward branching process of
the individual under consideration. This branching process has an offspring distribution that
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is Poisson distributed with mean pdR0,d. The offspring of an individual u are those individuals
that have an edge pointing towards u in the epidemic graph, i.e. those individuals that could
potentially infect u if they become infected themselves. The calculations in [3] provides us with
the following upper bound ρ+d (see also [3, Remark 4.1]):
ρ+d =
ηd
z
+
(
1−
ηd
z
) (2− ηd − z)pdR0,d
2
. (13)
Here, 0 ≤ ηd < 1 is the largest solution to
1− ηd = e
−pdR0,dηd , (14)
which is strictly between 0 and 1 if and only if pdR0,d > 1 and zero otherwise. Moreover, 1− ηd
can be interpreted as the probability that a randomly chosen individual is susceptible at the end
of epidemic when only symptomatic cases can reproduce (set λa = 0). We discuss ηd in more
detail in Section 3.3.
The lower bound ρ−d corresponding to (13) is obtained by interchanging the roles of sympto-
matic and asymptomatic cases, i.e.
ρ−d = 1− ρ
+
a (15)
where
ρ+a =
ηa
z
+
(
1−
ηa
z
) (2 − ηa − z)(1− pd)R0,a
2
. (16)
and 0 ≤ ηa < 1 is the largest solution to
1− ηa = e
−(1−pd)R0,aηa (17)
(which is strictly between 0 and 1 if and only if (1 − pd)R0,a > 1 and zero otherwise). Note
that (13) and (15) are not explicit since z, ηa, and ηd are only implicitly characterized through
equations (3), (14), and (17), respectively. Since ρ+d and ρ
−
d are upper- and lower bounds for
all distributions of the latent and infectious periods with fixed R0, R0,a, and R0,d (with some
technical restrictions, see [3] for details), we find that ρ−d ≤ θd ≤ ρ
+
d . Indeed, ρd = θd in the
special case that πa(τ) = πd(τ).
3.3 The epidemic curve for extreme settings
In this section we discuss the epidemic curve for the extreme setting where the mean latent period
E(La) is long relative to E(Ld), E(ιa), and E(ιd). To characterize the curve, we revisit (14) for
ηd. Suppose that pdR0,d > 1, then symptomatic individuals themselves can sustain an epidemic
(without asymptomatic cases reproducing) and 0 < ηd < 1 is unique and strictly positive. In
fact, if E(La) is relatively long, asymptomatic cases will initially not reproduce, and we are in
the setting of an epidemic outbreak generated by symptomatic individuals only. (Or, from a
stochastic viewpoint, there is a positive probability that this occurs, and we condition on this
happening.)
What happens after the epidemic ‘symptomatic’ outbreak? This very much depends on the
distributions for La, Ld, ιa, and ιd! In fact, we discuss the epidemic curves for the class of
continuous time Reed-Frost models and Markov models in Sections 3.3.1 and 3.3.2 below. The
upshot is that these two classes of models exhibit very different behaviour. Note that, when
pdR0,d < 1, there is no initial ‘symptomatic’ outbreak, and the epidemic curve takes the form of
a ‘standard’ curve.
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3.3.1 The continuous-time Reed-Frost model
In the continuous-time Reed-Frost model, latent and infectious periods are deterministic. There-
fore, we know with certainty that newly infected asymptomatic individuals will initially remain
in their latent period and do not transmit. There is a ‘symptomatic’ outbreak until there are
no more infectious symptomatics left. At this point, when the ‘first symptomatic wave’ of the
epidemic has occurred, the probability that a randomly chosen individual is susceptible is given
by 1− ηd. Note that this allows us to interpret the fraction ηd/z in (13) as the probability that
an individual was infected in the first wave of the epidemic, given that it got infected.
After the first wave, the epidemic continues when the asymptomatic cases of the first outbreak
become infectious. Additionally, there will be newly infected symptomatic cases. Together these
infectives generate a second wave of infections (where the asymptomatic cases generated in the
second wave are not yet infectious). The same reasoning as before yields the probability that
an individual escapes infection in the second wave, given that it escaped infection in the first
wave, is (1 − η2)/(1 − ηd). Here η2 denotes the fraction of infectives after the second wave (so
η1 := ηd would be consistent notation). Such an individual needs to escape infection from the
(1− pd)ηd asymptomatic individuals of the first wave as well as all the symptomatically infected
individuals from the second wave. Hence 0 < η2 < 1 is the unique solution to
1− η2
1− ηd
= e−
(
(1−pd)R0,aηd+pdR0,d(η2−ηd)
)
. (18)
Note that, contrary to the first wave, the second wave is not an epidemic outbreak per se. Indeed,
it starts with a significant fraction (1 − pd)ηd of latently infected individuals. The susceptible
population is of size 1 − ηd, and even if at the end of the second wave we have a fraction η2
infected individuals, we may have R0(1− ηd) < 1.
By the same reasoning, we find that
1− ηk
1− ηk−1
= e−
(
(1−pd)R0,a(ηk−1−ηk−2)+pdR0,d(ηk−ηk−1)
)
, (19)
for k ≥ 3, where 0 < ηk < 1 is the fraction of individuals infected in one of the first k waves (and
η1 = ηd). So, we find that the fraction of susceptibles depletes over time to 1 − z in an infinite
number of waves that are characterized by 1− ηd, 1− η2, 1− η3, . . . This qualitative multi-wave
process is illustrated in Figs. 1 and 2 of Section 4.
3.3.2 The Markov model
The crucial difference between the continuous-time Reed-Frost models and the Markov models is
that we now only know that on average newly infected asymptomatic individuals will remain in
their latent period during the ‘symptomatic outbreak’ since E(La) is relatively long. However,
due to the memoryless property of the exponential distribution, there is a constant probability
per unit of time that an asymptomatic case in the latent stage becomes infectious, regardless
of how long ago that individual got infected (in contrast to the continuous-time Reed-Frost of
Section 3.3.1 with deterministic latent periods).
Given that a major outbreak occurs, at first, the probability that any of the asymptomatic
cases become infectious in the ‘symptomatic outbreak’ is small enough to neglect. Therefore, as
in Section 3.3.1, the epidemic starts with a symptomatic outbreak that is characterized by ηd
satisfying (14). But, after the first ‘symptomatic’ wave, there is a significant fraction (1− pd)ηd
of asymptomatic individuals in the latent stage. These all have a constant probability per unit of
time to become infectious (whereas in Section 3.3.1 these asymptomatics became infectious more
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or less at the same time). As a result, after the first (symptomatic) wave, both symptomatic
and asymptomatic cases can transmit infection to the remaining susceptible population. The
susceptible fraction slowly decreases from 1 − ηd down to the fraction 1 − z. The time scale
at which this occurs is of the same order as E(La). In particular, the epidemic curve can be
approximated by a two-wave process rather than the multi-wave process of Section 3.3.1. This
qualitative two-wave process is illustrated in Fig. 2 of Section 4.
4 Numerical illustration
We consider different scenarios for the parameter values to illustrate the analytical results of this
paper. We use the system of ODE (7) and the system of DDE (9) for the numerical simulations
in this section.
4.1 Epidemic curves: Markov models vs. continuous-time Reed-Frost
models
We choose parameter values to illustrate (i) the extreme behaviour described in Sections 3.3.1
and 3.3.2 and (ii) the difference between the Markov (M) assumption and the Reed-Frost (RF)
assumption in temporal behaviour. We let R0 = 2, R0,d = 2.5, pd = 0.5 (consequently R0,a =
1.5). Note that the final sizes z and ηd, the lower- and upper bounds ρ
−
d and ρ
+
d , and the fraction
θd of R0 caused by symptomatic cases depend only on R0, R0,d, and pd. The values of these
epidemiological quantities for scenarios 1 and 2 are summarized in Table 1.
Epidemiological quantity z ηd ρ
−
d ρ
+
d θd
Value 0.80 0.37 0.55 0.74 0.63
Table 1: Epidemiological quantities evaluated for the parameter values R0 = 2, R0,d = 2.5, and pd = 0.5
(R0,a = 1.5).
When it comes to the time evolution of the epidemic, the mean values and the distribution
of La, Ld, ιa, and ιd start to matter as we will show using the M and RF assumption. We
consider the following two scenarios. We let E(Ld) = 0, E(ιa) = 0.10 = E(ιd). Scenarios 1 and
2 differ only in the mean latent period E(La) for asymptomatic cases: E(La) = 5 for scenario 1
and E(La) = 50000 for scenario 2. The reason for choosing such big differences in mean latent
periods between symptomatics and asymptomatics is to clearly illustrate the behaviour described
in Section 3.3. Furthermore, the scenarios are such that the RF model is close to the extreme
model that yields the upper bound ρ+d for all classes of models with the same pd, R0, and R0,d.
The epidemic curves for the two scenarios under the M and RF assumption are found in Figs. 1
and 2.
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Figure 1: Scenario 1 for the class of Markov models (M, yellow) and the class of continuous-time Reed-
Frost models (RF, blue). Parameter values are R0 = 2, R0,d = 2.5, pd = 0.5 (consequently R0,a = 1.5),
E(La) = 5, E(Ld) = 0, E(ιa) = 0.10 = E(ιd).
Note that, in both classes of models M and RF, according to theory, the fraction of suscept-
ibles monotonically decreases over time and reaches the level 1 − z, with z the final fraction
of infecteds in the epidemic. Furthermore, in Fig. 1, we find that the RF model displays the
extreme behaviour as described in Section 3.3.1. The level 1 − ηk of the kth wave is indeed
characterized by the equations (14)-(19). Next, we also note that the M model does not display
any extreme behaviour under scenario 1. In other words, the mean latent period E(La) is not
long enough (relatively speaking). In particular, we find that the two classes of models display
very different behaviour, i.e. a ‘multi-wave epidemic’ and a ‘standard epidemic’. In Fig. 2 we
consider scenario 2 and both the RF and M model exhibit the extreme behaviour described in
Sections 3.3.1 and 3.3.2.
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Figure 2: Scenario 2 for the class of Markov models and the class of continuous-time Reed-Frost models.
The inset figures zoom in on t ∈ (0, 25). Parameter values are R0 = 2, R0,d = 2.5, pd = 0.5 (consequently
R0,a = 1.5), E(La) = 50000, E(Ld) = 0, E(ιa) = 0.10 = E(ιd).
Evaluating ρd numerically yields 0.73 (M) and 0.74 (RF) for scenario 1 and 0.74 (M and RF)
for scenario 2. The upper bound (for both scenarios and classes of models) is ρ+d = 0.74; see
Table 1. Hence we find that the two scenarios are both extreme enough that they yield ρd close
to ρ+d . We find that there is a significant difference between ρd and θd = 0.63, i.e. symptomatic
cases play a different role for the beginning of an outbreak as in the final size of the epidemic.
Furthermore, when it comes to ρd, the M or RF assumption has little effect in the two scenarios
that we consider (this need not be true in general, see Section 4.2). But, we also find that the
time evolution of the epidemic are very different between the Markov and Reed-Frost models
(Figs. 1 and 2).
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4.2 Numerical investigation of ρd
We consider some numerical examples where parameter values are chosen to illustrate our beliefs
on the monotonicity of ρd that we stated in Section 3.2. We fix R0 = 3.2, R0,d = 3.5, and we
vary pd. These parameter values yield lower- and upper bounds ρ
−
d and ρ
+
d as functions of pd as
well as parameter θd in between the bounds; see Fig. 3. Fig. 3 illustrates that the range between
ρ−d and ρ
+
d can be quite wide. Next, we consider ρd for the M and RF models. We let E(La) = 1,
E(Ld) = 5, E(ιa) = 1.4, and E(ιd) = 2. The example of Fig. 3 supports our first general belief,
that ρd is an increasing function of pd.
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0.0
0.2
0.4
0.6
0.8
1.0
probability pd
ρd
+
θd
pd
ρd (M)
ρd (RF)
ρd
-
Figure 3: Varying pd for R0 = 3.2, R0,d = 3.5 (and R0,a is changed using (1)). Mean latent and
infectious periods are E(La) = 1, E(Ld) = 5, E(ιa) = 1.4, E(ιd) = 2.
For our second example, we fix pd = 0.5, R0 = 3.8, R0,d = 3.5, E(La) = 1, E(Ld) = 5,
E(ιa) = 1.4, and vary λd (consequently we also vary E(ιd)); see Fig. 4 for the result. Note that
also R0,a is fixed (at 4.1). Then ρ
+
d , ρ
−
d , θd, and pd are constants as a function of λd. On the
other hand, in this example, ρd(M) and ρd(RF ) are both monotonically increasing functions of
λd, which supports our second conjecture.
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Figure 4: Varying λd for pd = 0.5, R0 = 3.8, R0,d = 3.5 (and R0,a = 4.1). Mean latent and infectious
periods are E(La) = 1, E(Ld) = 5, E(ιa) = 1.4 (and E(ιd) varies according to (1)).
4.3 Illustration with norovirus and measles
We take two scenarios ‘norovirus’ and ‘measles’ that represent real-life epidemics with parameter
values in reasonable ranges taken from literature. This section serves to illustrate the role of ρd.
By no means do we try to incorporate the complexity of the two infections.
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Scenario R0 R0,d R0,a pd E(La) E(Ld) E(ιa) E(ιd)
Norovirus 1.40 1.64 0.85 0.70 1.5 1.5 19.3 25.3
Measles 2.47 17 0.85 0.1 7 7 0.5 5.0
Table 2: Parameter values for the two scenarios ‘norovirus’ and ‘measles’.
The first scenario represents a norovirus outbreak in a hospital setting, and we take reference
values based on [9, 10]. From [10], we obtain pd = 0.7, duration of shedding E(ιa) = 19.3 days
and E(ιd) = 25.3 days, and mean latent periods E(La) = 1.5 days = E(Ld). [9] report estimated
reproduction numbers of R0,a = 0.85 and R0,d = 1.64 for asymptomatic and symptomatic
cases respectively. Furthermore, from their data, we find pd = 0.7 consistent with [10]. Hence
R0 = 1.38.
The second scenario represents measles in England in the vaccine era with subclinical infec-
tions. We base parameter values for the reproduction numbers, pd, and mean infectious periods
on [11, Fig. 1]. Unvaccinated individuals that are infected are symptomatic and have a high re-
production number. Vaccinated individuals could potentially become asymptomatically infected
but these have a very short infectious period and low reproduction number (in [11] the possibility
of asymptomatic infection is related to antibody decay). The model in [11] is used to address a
completely different question related to waning and boosting of immunity, and does not include
any latent period. For our purposes we let mean latent periods be E(La) = 7 days = E(Ld),
coinciding with a reasonable incubation period [12]. Again, we do not try to fit our model to
any real measles outbreak, but rather want to illustrate the use of the quantity ρd by considering
reasonable parameter values.
Parameter values for both scenarios are summarized in Table 2. Note that both scenarios
have R0 > 1 and pdR0,d > 1. The resulting epidemic curves are presented in Fig. 5 for both the
M and the RF model. Note that, for both scenarios, the curves of both the M and RF model
are of a ‘standard epidemic’. Qualitatively, the two curves are similar. However, when it comes
to the quantitative dynamics, we do find that the assumption on the distribution of the latent
and infectious periods matter.
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Figure 5: Illustration of the evolution of the fraction of susceptible and recovered individuals for
parameter values representing the scenarios norovirus, and measles for the class of M and RF models.
Note the time scales of the epidemic outbreaks for our simple models are not representative for real
outbreaks. Parameter values are summarized in Table 2.
Next, we consider the fraction ρd of cases that were caused by symptomatic individuals, given
that they were ultimately infected in Table 3. Note that lower- and upper bounds ρ−d and ρ
+
d
are only dependent on pd, R0, and R0,d and are calculated using (15) and (13). We find that (i)
for both the scenarios that the RF and the M model assumption yield similar values for ρd (ii)
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the upper- and lower-bounds ρ+d and ρ
−
d are narrow for the norovirus scenario but wider for the
measles scenario, and (iii) for both scenarios ρd and θd are close to each other for both the RF and
the M model assumption. Furthermore, while the measles scenario has only a small proportion
pd = 0.1 of infected individuals that become symptomatic, both in the beginning of the epidemic
and in the final size, they play a much bigger role than the asymptomatic cases. Indeed, we find
that symptomatic cases contribute between ρ−d = 0.57 and ρ
+
d = 0.86 of all transmissions that
occur in the epidemic. In the norovirus scenario, this difference in the fractions pd and ρd is
not as extreme. Still we find that the contribution of symptomatic cases to the transmissions is
between ρ−d = 0.81 and ρ
+
d = 0.85, which is larger than would be expected based on pd = 0.7
alone. We find that symptomatic cases cause most of the infections in the norovirus scenario.
This is consistent with the findings of [9] that symptomatic cases contributed most to the spread
of infection in the outbreak settings that they analysed (incidentally, the outbreak duration is
not consistent with [9]).
Scenario z ηd ρ
−
d ρd (RF) ρd (M) θd ρ
+
d
Norovirus 0.49 0.25 0.81 0.82 0.82 0.82 0.85
Measles 0.89 0.69 0.57 0.67 0.65 0.69 0.86
Table 3: The fraction ρd of the final size z that is caused by symptomatic cases for norovirus and
measles. ρ−d and ρ
+
d denote the lower- and upper bound for ρd, ρd (RF) and ρd (M) are the numerical
approximations of ρd under the RF and M assumption, and θd is the fraction of secondary cases at the
beginning of the outbreak that are caused by symptomatic cases.
5 Conclusion and discussion
In this paper we considered an SEIRmodel with symptomatic and asymptomatic cases and looked
at the fraction ρd of the infected individuals that was caused by symptomatic cases. The quantity
ρd gives an indication of the importance of symptomatic cases in the transmission process in an
epidemic. In general, it is hard to make statements about ρd as timing of transmission events
matter: a susceptible individual that gets infected by an asymptomatic case can no longer become
infected by a symptomatic case. We were only able to derive an explicit expression for ρd for
the simple situation where the latent and infectious period distributions of symptomatic and
asymptomatic coincide.
Instead we used this timing issue to our advantage. We considered extreme settings for
the latent and infectious periods of symptomatics and asymptomatics. The current paper is
accompanied by a twin paper [3] in which the arguments and reasoning are made precise (in a
more general setting than we consider here). The extreme setting allowed us to derive an upper
and lower bound ρ+d and ρ
−
d for ρd. The bounds ρ
+
d and ρ
−
d are the bounds for fixed R0,d, R0,a
and pd but unspecified latent and infectious periods. Although the expressions for ρ
+
d and ρ
−
d
are still implicit (depending on some implicit final size equations) they are relatively simple and
easily obtained. We studied ρd and the bounds numerically in Section 4. It was seen that the
biggest range of possible values of ρd, i.e. the biggest difference between ρ
−
d and ρ
+
d , is for the
situation where both symptomatics and asymptomatics separately have big enough reproduction
numbers to produce an outbreak on their own: pdR0,d > 1 and paR0,a > 1 as seen in Fig. 3.
We stated two rather natural beliefs for the general model, namely that ρd increases with
increasing fraction pd of infecteds that become symptomatic, and that ρd increases with increasing
infectious contact rate λd from symptomatic cases. Unfortunately we were not able to prove either
statement, also not using the techniques employed in [3], at least not in a straightforward way.
Instead we pose these two statements as open problems for future work.
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We paid special attention to two special classes of models, namely the class of Markov models
(with latent and infectious periods exponentially distributed) and continuous-time Reed-Frost
models (with deterministic latent and infectious periods). We specifically considered the epidemic
curve in the extreme setting with fixed mean latent and infectious periods in Sections 3.3.1
and 3.3.2 and found large differences in the qualitative behaviour of the two classes of models. In
other words, not only the means but also the distributions matter! At this point, we hope that
Sections 3.3.1 and 3.3.2 and Figs. 1 and 2 have convinced readers that the choice of distribution
functions matter. This fact is of course not new and has been observed before in different settings
(e.g. [6, 13, 14, 15, 16, 17]). The distribution of the infectivity profile can matter a lot. However,
how much it matters depends on the aspects of the epidemic model that one considers. In
case of R0, it is the mean infectious period that matters and not its distribution. In case of
the Malthusian parameter (or as we have seen in this paper, the epidemic curve), the choice of
distributions can matter a lot. Assuming exponential distributions for mathematical convenience
could prove dangerous when not also considering the possible influences of this assumption. The
qualitative outcome can be dramatically different depending on other choices. The critical reader
will now point out that parameter values of Figs. 1 and 2 probably do not fit any reasonable
known disease. This is a valid criticism. However, our first aim was to illustrate possible effects.
Moreover, much more reasonable parameter values can be chosen such that the assumption of
constant periods create a multi-wave epidemic while the Markov assumption yields a ‘standard’
epidemic curve (Fig. 1). Finally, while one can argue about the realism of the simple models
and parameter values used in this text, we hope to have reminded the reader that conclusions
are always based on the assumptions that one makes. Furthermore, we hope one keeps in mind
that it is worth exploring what the possible differences are by assuming something other than
exponential distributions.
Studying the end of the epidemic and the question of who the infector was is more involved
than studying R0 for the beginning of the epidemic. We managed to gain insights by providing
bounds. This increased understanding of the transmission dynamics may help us in deciding the
role that asymptomatic cases can play, and how their role may differ throughout an epidemic
outbreak.
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